Green Elephant Biotech announced the introduction of the Archimedes® One — Dynamic Adherent Bioreactor, a new platform designed to simplify and scale adherent cell culture processes. The system was developed in close collaboration with Bürkert Fluid Control Systems, combining Green Elephant Biotech’s cultivation technology with Bürkert’s expertise in fluidic control and automation. The collaboration between […]

Royston Instruments Announces Acquisition of Controlling Stake in Biosan, Strengthening Global Life-Science and Laboratory Instrumentation Capabilities Royston, United Kingdom, 19th March 2026, Royston Instruments Ltd, a diversified technology group focused on advancing scientific instrumentation and data acquisition solutions, today announced that it has acquired a controlling stake in Biosan SIA, the Riga-based developer and manufacturer […]

ViaPlex™ enables fluorescent barcoding of up to 15 cell populations in a single tube to reduce reagent use, save time, and increase throughput for flow cytometry workflows. FREMONT, CA — Biotium, a leading provider of fluorescent reagents and kits for life science research, announces the release of the ViaPlex™ 2-Color Cell Barcoding Kit. Combining fluorescent staining with two […]

Stockholm, Sweden — Epigenica AB, a company commercializing advanced tools for epigenetic analysis, today announced a distribution agreement with PrimeTech Co., Ltd., a leading distributor of life science technologies in Japan. The partnership will bring Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market. Japan represents one of the world’s most advanced life science […]

Genovis AB, a leading provider of innovative enzyme technologies, today announces a strategic partnership with Single Cell Discoveries to broaden the application of the SEQURNA® Thermostable RNase Inhibitor across advanced single-cell and bulk RNA-sequencing workflows. The collaboration brings together Genovis’ expertise in developing high-performance molecular tools and Single Cell Discoveries’ extensive experience in RNA sequencing […]

The Gene Therapy Vector Facility at King’s College London announced the addition of the Univercells Technologies’ scale-X™ carbo bioreactor to its GMP manufacturing portfolio The Gene Therapy Vector Facility at King’s College London announced the addition of the Univercells Technologies’ scale-X™ carbo bioreactor to its GMP manufacturing portfolio, further strengthening our capabilities for adeno associated […]

LONDON, UK — Touchlight, in collaboration with New England Biolabs (NEB®), announces the launch of the EnClose™ Cell-free dbDNA™ Synthesis Kit, a new benchtop solution enabling rapid enzymatic production of Touchlight’s proprietary doggybone DNA™ (dbDNA™). This linear, covalently closed, double-stranded DNA format offers researchers a fast, cell-free alternative to traditional plasmid DNA, supporting the growing demand for nucleic acid […]

World First: Quintessence Biotech reinvents bio-separation to remove the manufacturing bottleneck that has kept cell and gene therapy available to only 1% of eligible patients. CGT can finally become a standard of care. Up to 60% reduction in cost of goods (COGS) through radical process simplification 12× more therapeutic doses produced per site Doubling therapeutic […]

Prof. Andreas Lundqvist’s group will use Pixelgen’s Proximity Network Assay to explore spatial distribution and abundance of single cell surface proteins in non-small cell lung cancer STOCKHOLM — Pixelgen Technologies today announced a research collaboration with Andreas Lundqvist’s Group at the Department of Oncology-Pathology, Karolinska Institutet, to discover novel biomarkers for cancer immunotherapy response using […]

BOZEMAN, Mont. — Golden Helix, a global leader in bioinformatics solutions for Next-Generation Sequencing (NGS) and precision medicine, is proud to announce a strategic agreement with the Austrian public medical genetics labs. The agreement aims to enhance the genomic capabilities of multiple laboratories within the country, supporting critical advancements in cancer and hereditary disease diagnostics. […]